Pharming Group NV reports results for the quarter ended June 30 - Earnings Summary

• Pharming Group NV PHAR.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported breakeven earnings per share. The lone analyst forecast for the quarter was for a loss of 2 cents per share.

• Revenue rose 25.8% to $93.20 million from a year ago; analysts expected $83.26 million.

• Pharming Group NV's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $4.6 million.

• Pharming Group NV shares had fallen by 5.6% this quarter and gained 0.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 233.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

This summary was machine generated from LSEG data July 31 at 06:00 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)